- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
CMS gears up Medicare Part D for 2007
CMS has begun preparations for the 2007 Medicare Part D benefit, releasing a draft of Chapter 6 of the Medicare Part D manual, a checklist for drug coverage plans, and announcing the release of a new version of the E1 system that will go live in December.
CMS has begun preparations for the 2007 Medicare Part D benefit, releasing a draft of Chapter 6 of the Medicare Part D manual, a checklist for drug coverage plans, and announcing the release of a new version of the E1 system that will go live in December. The new E1 version will include new data elements to assist pharmacies with processing beneficiary prescriptions as well as a data field, and more specific messaging capabilities. CMS is also accepting comments on the revised draft of Chapter 6 of the Medicare Part D manual, which contains information specific to the definition of a Part D drug, Part D exclusions, formulary requirements, and transition. Comments will be accepted until 5:00 P.M. EST, Tuesday, Sept. 26. The chapter and directions for submitting comments can be found at: www.cms.hhs.gov/PrescriptionDrugCovContra/Downloads/PartDManual_Chapter6.pdf.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Implementing Interpersonal Care Model for PPHTN Can Help Manage Blood Pressure Control
December 5th 2023A poster presented at ASHP Midyear 2023 highlighted the positive impact of including pharmacists in the care of postpartum women at risk of persistently elevated blood pressure (BP), particularly in cases of portopulmonary hypertension (PPHTN).
Instagram Could Serve as Educational Platform for New FDA Drug Approvals
December 4th 2023An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.
